SEC filing record
Primary Source · SEC.gov

NWF Medical DST

Single-Deal SPV2026 vintage506(c)
Latest signalNew Form D filerForm D · 2026-11-02Last filing 2026-11-02

Raised

$396K

Investors

1

Min Invest

$50,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

AltStreet Analysis

·

Generated from EDGAR primary sources

NWF Medical DST is a Delaware statutory trust formed to raise equity capital under Rule 506(c), with Duane Lund and Exchange Realty, Inc. listed as promoters/executive officer. The filing reports $396K raised from a single investor against a $50K minimum investment threshold, with no confirmed parent platform or related entity cluster identified in available records.

This filing sits at the small end of the alternative_investment spectrum, consistent with a single-asset Delaware statutory trust (DST) offering often used in real estate/1031-exchange style structuring, rather than a diversified fund. A $50K minimum and single-investor, sub-$500K raise under 506(c) is typical for an early or narrowly marketed DST closing, not a large institutional vehicle.

Data Flags

First Sale DateNo first sale date disclosed on an offering with total proceeds under $100M; this is a data gap worth noting on a smaller, non-institutional filing.
Total InvestorsEntire $396K raised to date came from a single investor, suggesting an initial/anchor close rather than a broadly distributed offering.
Sales CommissionsNo sales commissions stated, consistent with a direct, sponsor-led placement rather than broker-dealer distribution.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002162871
Entity NameNWF Medical DST
ExemptionRule 506(c)
What the exemption meansRule 506(c) of Regulation D: the issuer may advertise the offering publicly, but every purchaser must be a verified accredited investor.
Entity TypeOther
Jurisdiction of OrganizationDelaware
Year Organized2026
Issuer Address4400 W 78th St, 120, Bloomington, MN 55435
Phone(952) 239-6360
Industry / Fund TypeCommercial
Securities TypeEquity
First Sale Date—
Filing DateNovember 2, 2026
Accession Number0002162871-26-000001
Total Offering Amount$3,655,740
Total Amount Sold$395,707
Amount Remaining$3,260,033
Total Investors1
Non-Accredited InvestorsNone
Minimum Investment$50,000
Offering DurationOne year or less
Sales Commissions$255,902
Finders' Fees$0
Proceeds to Related Persons$403,507
Revenue RangeDecline to Disclose
State (Issuer Address)MN
Amendment CountOriginal filing only
Signed ByDuane H Lund, Manager of NWF Medical Manager, LLC, as signatory trustee

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

1

latest Nov 2, 2026

Critical / warning

0 / 0

0 watch · 1 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

raising

Latest event New filer · Nov 2, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 1 filing event with values and deltas, latest 2026-11-02, and alerts on the next one
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Duane Lund

Executive Officer, Promoter · Bloomington, MN

- Exchange Realty, Inc.

Promoter · Bloomington, MN

Questions About NWF Medical DST

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is NWF Medical DST?

NWF Medical DST is a Delaware entity organized in 2026 that filed a Form D with the SEC on November 2, 2026 in the Commercial industry group. The filing claims Rule 506(c) for an offering of equity.

Is NWF Medical DST legit?

AltStreet does not rate legitimacy; it reports the public record. NWF Medical DST filed a Form D with the SEC on November 2, 2026 claiming Rule 506(c). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $395,707 sold to 1 investor. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is NWF Medical DST registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that NWF Medical DST claimed Rule 506(c) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has NWF Medical DST raised?

NWF Medical DST reported $395,707 sold from 1 investor of a $3,655,740 total offering as of the Form D filed November 2, 2026.

Who can invest in NWF Medical DST?

The offering relies on Rule 506(c), so the issuer may advertise it but may sell only to investors it has verified as accredited. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $50,000.

What is the minimum investment in NWF Medical DST?

The Form D lists $50,000 as the minimum investment accepted from any outside investor as of November 2, 2026. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling NWF Medical DST and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $255,902 and finders' fees as $0. Form D allows these to be estimates. The issuer reports $403,507 of gross proceeds used or proposed to be used for payments to related persons.

Who is behind NWF Medical DST?

The Form D lists 2 related persons: Duane H Lund, executive officer, promoter (Manager of NWF Medical Manager, LLC, the signatory trustee of the issuer, and President of Exchange Realty, Inc., the sponsor); Exchange Realty, Inc., promoter (Sponsor of the offering and initial beneficial owner of the issuer). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is NWF Medical DST located?

The issuer's address on its SEC filings is 4400 W 78th St, 120, Bloomington, MN 55435. Its phone number of record is 9522396360. It is organized under the laws of Delaware.

How long is the NWF Medical DST offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

What is NWF Medical DST's revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.